Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06330064
What this trial is testing

Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Who this might be right for
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo 680
Testing effectiveness (Phase 2)UnknownNCT01377298
What this trial is testing

Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
National Taiwan University Hospital 45
Testing effectiveness (Phase 2)WithdrawnNCT04093115
What this trial is testing

Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Beijing Konruns Pharmaceutical Co., Ltd.
Testing effectiveness (Phase 2)Study completedNCT00116909
What this trial is testing

OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy

Who this might be right for
Locally Recurrent or Metastatic Cancer of the Head and NeckMust Have Failed First-Line Therapy
OSI Pharmaceuticals 85
Testing effectiveness (Phase 2)Study completedNCT00005599
What this trial is testing

Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00020189
What this trial is testing

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck CancerThromboembolism
National Cancer Institute (NCI)
Large-scale testing (Phase 3)WithdrawnNCT04129320
What this trial is testing

Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of Head and Neck
MacroGenics
Testing effectiveness (Phase 2)Ended earlyNCT00573989
What this trial is testing

Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Wake Forest University Health Sciences 27
Testing effectiveness (Phase 2)UnknownNCT00690872
What this trial is testing

Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Centre, Singapore 35
Early research (Phase 1)Study completedNCT00011778
What this trial is testing

PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma
National Cancer Institute (NCI) 25
Large-scale testing (Phase 3)Study completedNCT02252042
What this trial is testing

Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)

Who this might be right for
Head and Neck Squamous Cell Cancer
Merck Sharp & Dohme LLC 495
Large-scale testing (Phase 3)Active Not RecruitingNCT04534205
What this trial is testing

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

Who this might be right for
Unresectable Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck CancerRecurrent Head and Neck Cancer
BioNTech SE 358
Large-scale testing (Phase 3)Looking for participantsNCT07264075
What this trial is testing

Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN

Who this might be right for
Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
Groupe Oncologie Radiotherapie Tete et Cou 780
Large-scale testing (Phase 3)Study completedNCT00002507
What this trial is testing

Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer

Who this might be right for
Carcinoma of Unknown PrimaryHead and Neck Cancer
Yale University
Early research (Phase 1)Study completedNCT00006107
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 31
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Testing effectiveness (Phase 2)Ended earlyNCT05363605
What this trial is testing

[225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more
Fusion Pharmaceuticals Inc. 6
Testing effectiveness (Phase 2)Study completedNCT00022594
What this trial is testing

Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 50
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Testing effectiveness (Phase 2)Study completedNCT02255097
What this trial is testing

Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 172
Next Page